Home › No Rehearing Of Biosimilar Patent Dance Decision
 

Keywords :   


No Rehearing Of Biosimilar Patent Dance Decision

2015-10-21 00:14:28| Biotech - Topix.net

The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. Sandoz Inc. , which was the court's first decision interpreting the Biologics Price Competition and Innovation Act .

Tags: decision dance patent rehearing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Benefits of benchmarking in the pork industry
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
More »